Preview

Biosafety and Biotechnology

Advanced search

SELECTING AN OPTIMAL ADJUVANT SYSTEM FOR AN EXPERIMENTAL ASSOCIATED VACCINE AGAINST INFECTIOUS BOVINE RHINOTRACHEITIS AND VIRAL DIARRHEA: A COMPARATIVE STUDY IN A RABBIT MODEL

https://doi.org/10.58318/2957-5702-2026-26-75-87

Abstract

Infectious bovine rhinotracheitis (IBR) and bovine viral diarrhea (BVD) are among the most common viral infections causing significant economic losses in livestock production. The efficacy of inactivated vaccines against these diseases is largely determined by the choice of an adjuvant system that ensures the formation of a pronounced and long-lasting immune response. The aim of this study was to comparatively evaluate the physical stability, safety, and immunogenicity of an experimental associated inactivated vaccine against IBR and BVD formulated with various commercial Montanide® adjuvants to substantiate the choice of the optimal adjuvant system. Experimental vaccines formulations were prepared based on inactivated virus-containing suspensions of the IBR virus strain “R-93” and the BVD virus strain “OregonC24V” using Montanide ISA 70 VG, Montanide ISA 61 VG, and Montanide GEL 01 PR adjuvants. The physical stability of the vaccines was assessed using an accelerated thermostability test, while safety and immunogenicity were assessed in a rabbit model following a single intramuscular immunization, with determination of virus-neutralizing antibody (VNA) titers in a neutralization test. All studied vaccines maintained physical stability for 10 days of incubation, did not cause clinically significant local adverse reactions, and were well tolerated. The highest VNA titers to both viruses were observed in the groups immunized with vaccines formulated with Montanide ISA 70 VG and Montanide GEL 01 PR, while antigens without adjuvant induced a less pronounced humoral immune response. This comprehensive evaluation supported the selection of Montanide ISA 70 VG as the optimal adjuvant for the domestic associated inactivated vaccine against IBR and BVD.

About the Authors

A. Kurmasheva
“Kazakh National Agrarian Research University”
Kazakhstan

Almaty 



Z. Sametova
“Research Institute for Biological Safety Problems” National Holding “QazBioPharm”
Kazakhstan

Gvardeyskiy 



Z. Amanova
“Research Institute for Biological Safety Problems” National Holding “QazBioPharm”
Kazakhstan

Gvardeyskiy 



A. Ussembay
“Kyrgyz National Agrarian University named after K.I. Skryabin”
Kyrgyzstan

Bishkek 



R. Abitayev
“Research Institute for Biological Safety Problems” National Holding “QazBioPharm”
Kazakhstan

Gvardeyskiy 



S. Turiskeldy
“Research Institute for Biological Safety Problems” National Holding “QazBioPharm”
Kazakhstan

Gvardeyskiy 



D. Toktyrova
“Research Institute for Biological Safety Problems” National Holding “QazBioPharm”
Kazakhstan

Gvardeyskiy 



Z. Kondibayeva
“Research Institute for Biological Safety Problems” National Holding “QazBioPharm”
Kazakhstan

Gvardeyskiy 



References

1. Bulatov E.A., Kurmasheva A.K. (2024) Infekcionnyj rinotraheit krupnogo rogatogo skota: kratkij obzor [Infectious bovine rhinotracheitis: a brief overview]. Biosafety and Biotechnology, no 18, pp. 19-43. https://doi.org/10.58318/2957-5702-2024-18-19-43.

2. Cui H., Ren B., Wang L., Chen J., Li J., Hu W., Yang Y. Enhanced pathogenicity and synergistic effects of co-infection with bovine viral diarrhea virus 1 and HoBi-like virus in cattle and guinea pigs // Front. Vet. Sci. – 2024. – Vol. 11. – P. 1464745. https://doi.org/10.3389/fvets.2024.1464745.

3. Newcomer B.W., Walz P.H., Givens M.D., Wilson A.E. Efficacy of bovine viral diarrhea virus vaccination to prevent reproductive disease: A meta-analysis // Theriogenology. – 2015. – Vol. 83 (3). – P. 360–365.e1. https://doi.org/10.1016/j.theriogenology.2014.09.028.

4. Hou Z., Wang J., Tan B., Zhang S. A systematic study of bovine viral diarrhoea virus coinfection with other pathogens // Viruses. – 2025. – Vol. 17 (5). – P. 700. https://doi.org/10.3390/v17050700.

5. Barrett D., Lane E.A., Lozano J.M., O'Keeffe K., Byrne A.W. Bovine herpes virus type 1 (BoHV-1) seroprevalence, risk factor and bovine viral diarrhoea (BVD) co-infection analysis from Ireland // Sci. Rep. – 2024. – Vol. 14 (1). – P. 867. https://doi.org/10.1038/s41598-023-50433-5.

6. Omarova G., Bajkadamova G., Akanova ZH., Asauova ZH. (2024) Seroprevalentnost' infekcionnogo rinotraheita krupnogo rogatogo skota v Kazahstane: dinamika rasprostraneniya v 2021-2022 godah [Seroprevalence of infectious bovine rhinotracheitis in Kazakhstan: propagation dynamics in 2021-2022]. 3i: intellect, idea, innovation, no 4, pp. 16–23. https://doi.org/10.52269/22266070_2024_4_16.

7. Bashenova E., Nisanova R., Zharmuhametova A., Akshalova P., Serikov M., Mamanova S., Kirpichenko V. (2024) Otbor vysokopozitivnyh obrazcov syvorotki krovi ot krupnogo rogatogo skota, inficirovannogo virusnoj diareej [Selection of strong positive serum samples from cattle infected with bovine viral diarrhea]. Eurasian Journal of Applied Biotechnology, no 3, pp. 66–72. https://doi.org/10.11134/btp.3.2024.7.

8. Smith B.I., Rieger R.H., Dickens C.M., Schultz R.D., Aceto H. Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine // Am. J. Vet. Res. – 2015. – Vol. 76 (10). – P. 913–920. https://doi.org/10.2460/ajvr.76.10.913.

9. Bulatov Y., Kurmasheva A., Amanova Z., Abitaev R., Sametova Z., Kyrgyzbayeva A., Kondybaeva Z., Turyskeldi S., Ussembay A., Toktyrova D., Mazbayeva D., Shayakhmetov Y., Kerimbayev A., Khussainov D., Wentao M., Rsaliyev A., Abduraimov Y. The Influence of the associated inactivated vaccine against infectious rhinotracheitis and bovine viral diarrhea on the formation and duration of colostral immunity in kazakh whiteheaded calves // Vaccines. – 2025. – Vol. 13(4) – P. 408. https://doi.org/10.3390/vaccines13040408.

10. Frey M.L. One year antibody responses of four inactivated infectious bovine rhinotracheitis-bovine viral diarrhea vaccines // Bov. Pract. – 1989. – Vol. 24. – P. 18–21. https://doi.org/10.21423/bovine-vol0no24p18-21.

11. Ahmed D.A.A., Sadiek Y., Eldin M.S., Ibrahim R.S., Amen O., Abodalal S.E.S.A. Evaluation of comparative effect between aluminum hydroxide gel and montanide (ISA 70) in potency and protection of locally prepared rabbit hemorrhagic disease virus 2 (RHDV2) vaccines in rabbits // BMC Vet. Res. – 2024. – Vol. 20 (1). – P. 407. https://doi.org/10.1186/s12917-024-04239-w.

12. Fegan J.E., Waeckerlin R.C., Tesfaw L., Islam E.A., Deresse G., Dufera D., Assefa E., Woldemedhin W., Legesse A., Akalu M., Bayissa B., Nguyen Q.H., Ng D., Ahn S.K., Schryvers A.B., Tefera T.A., Moraes T.F., Gray-Owen S.D. Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia–causing serogroup B and E strains of Pasteurella multocida in cattle // Front. Immunol. – 2024. – Vol. 15. – P. 1392681. https://doi.org/10.3389/fimmu.2024.1392681.

13. Zhang S., Zhang Y., Liu G., Wang C., Ji Y., Chen J., Hu C., Chen X., Guo A., Chen Y. The safety and protective efficacy evaluation of an attenuated M. bovis-BoHV-1 bivalent vaccine in rabbits // Vaccines. – 2023. – Vol. 11 (11). – P. 1698. https://doi.org/10.3390/vaccines11111698.

14. Ruiz-Sáenz J., Jaime J., Vera V. An inactivated vaccine from a field strain of bovine herpesvirus-1 (BoHV-1) has high antigenic mass and induces strong efficacy in a rabbit model // Virol. Sin. – 2013. – Vol. 28 (1). – P. 36–42. https://doi.org/10.1007/s12250-013-3283-z.

15. Donofrio G., Cavirani S., Vanderplasschen A., Gillet L., Flammini C.F. Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model // Clin. Vaccine Immunol. – 2006. – Vol. 13 (11). – P. 1246–1254. https://doi.org/10.1128/CVI.00200-06.

16. Yao Y., Zhang Z., Yang Z. The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine // Front. Vet. Sci. – 2023. – Vol. 10. – P. 1243835. https://doi.org/10.3389/fvets.2023.1243835.

17. Jansen T., Hofmans M., Theelen M., Schijns V. Structure–activity relations of water-inoil vaccine formulations and induced antigen-specific antibody responses // Vaccine. – 2005. – Vol. 23 (8). – P. 1053–1060. https://doi.org/10.1016/j.vaccine.2004.08.023.

18. Balashov A.N., Doronin M.I., Borisov A.V., Lozovoj D.A., Mihalishin D.V., Starikov V.A. (2020) Izuchenie gumoral'nogo immuniteta sobak pri ispol'zovanii antirabicheskih inaktivirovannyh vakcin, izgotovlennyh s primeneniem ad"yuvantov Montanide ISA 70 VG i GEL 01 [Studies on humoral immunity in dogs after use of rabies inactivated vaccines formulated with Montanide ISA 70 VG and GEL 01 adjuvants]. Veterinary Science Today, no 1 (32), pp. 25–30. https://doi.org/10.29326/2304-196X-2020-1-32-25-30.

19. Khorasani A., Madadgar O., Soleimanjahi H., Keyvanfar H., Mahravani H. Evaluation of the efficacy of a new oil-based adjuvant ISA 61 VG FMD vaccine as a potential vaccine for cattle // Iran. J. Vet. Res. – 2016. – Vol. 17 (1). – P. 8–12. https://doi.org/10.22099/IJVR.2016.3596.

20. Bulatov Y., Sametova Z., Abitayev R., Kyrgyzbayeva A., Ussembay A., Kondibaeva Z., Amanova Z., Turyskeldy S., Toktyrova D., Mazbayeva D., Shorayeva K., Jekebekov K., Zhugunissov K., Barakbayev K., Kerimbayev A., Rsaliyev A., Abduraimov Y., Kurmasheva A. Duration of immunity against infectious rhinotracheitis and bovine viral diarrhea after vaccination in calves in southern region of Kazakhstan // Front. Vet. Sci. – 2025. – Vol. 12. – P. 1681624. https://doi.org/10.3389/fvets.2025.1681624.


Review

For citations:


Kurmasheva A., Sametova Z., Amanova Z., Ussembay A., Abitayev R., Turiskeldy S., Toktyrova D., Kondibayeva Z. SELECTING AN OPTIMAL ADJUVANT SYSTEM FOR AN EXPERIMENTAL ASSOCIATED VACCINE AGAINST INFECTIOUS BOVINE RHINOTRACHEITIS AND VIRAL DIARRHEA: A COMPARATIVE STUDY IN A RABBIT MODEL. Biosafety and Biotechnology. 2026;1(26):75-87. (In Russ.) https://doi.org/10.58318/2957-5702-2026-26-75-87

Views: 17

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2707-7241 (Print)
ISSN 2957-5702 (Online)